As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.

Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The ...

A new analytical method could improve how cancer treatments are designed—by allowing scientists to track, for the first time, ...

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most ...

ZFTA–RELA is the cancer-promoting protein product of a gene fusion. Analyses of accessible sites in the DNA–protein complex chromatin in developing mice show that ZFTA–RELA binds to chromatin modules ...

Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

A new study led by researchers at the University of Liège highlights the unexpected role of Stard7 in the development of intestinal cancers.

Researchers found that pancreatic pre-cancer cells mimic dementia by forming clumps of proteins due to faulty recycling processes. These insights could shed light on why pancreatic cancer develops so ...

Trastuzumab pamirtecan, being developed under a 2023 partnership between BioNTech and DualityBio, elicited a 44.1% overall ...